ModelEdge

CTI BioPharma Corp
0000891293
Filing Type8-K
Filing Date6/25/2023
Updated6/26/23, 2:51 AM

Filing

8-K
Earnings Release

Exhibits

8-KEnd of Material Contract, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Chan
EX-3.1EX-3.1
EX-3.2EX-3.2